UNTREATED MYELODYSPLASTIC SYNDROME

Clinical trials for UNTREATED MYELODYSPLASTIC SYNDROME explained in plain language.

Never miss a new study

Get alerted when new UNTREATED MYELODYSPLASTIC SYNDROME trials appear

Sign up with your email to follow new studies for UNTREATED MYELODYSPLASTIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Oral combo trial aims to control aggressive blood disorder

Disease control Ongoing

This early-stage study is testing the safety and initial effectiveness of a combination of two oral drugs, Onureg and Venetoclax, for people with untreated high-risk myelodysplastic syndrome (MDS) who cannot receive a stem cell transplant. The main goal is to find the safest and …

Matched conditions: UNTREATED MYELODYSPLASTIC SYNDROME

Phase: PHASE1, PHASE2 • Sponsor: Groupe Francophone des Myelodysplasies • Aim: Disease control

Last updated Mar 23, 2026 15:14 UTC

UNTREATED MYELODYSPLASTIC SYNDROME

Get alerted when new UNTREATED MYELODYSPLASTIC SYNDROME trials appear

Oral combo trial aims to control aggressive blood disorder